P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice

Christian Furlan-Freguia, Patrizia Marchese, Andras Gruber, Zaverio M. Ruggeri, Wolfram Ruf

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

Thrombosis is initiated by tissue factor (TF), a coagulation cofactor/receptor expressed in the vessel wall, on myeloid cells, and on microparticles (MPs) with variable procoagulant activity. However, the molecular pathways that generate prothrombotic TF in vivo are poorly defined. The oxidoreductase protein disulfide isomerase (PDI) is thought to be involved in the activation of TF. Here, we found that in mouse myeloid cells, ATP-triggered signaling through purinergic receptor P2X, ligand-gated ion channel, 7 (P2X7 receptor; encoded by P2rx7) induced activation (decryption) of TF procoagulant activity and promoted release of TF+ MPs from macrophages and SMCs. The generation of prothrombotic MPs required P2X7 receptor-dependent production of ROS leading to increased availability of solvent-accessible extracellular thiols. An antibody to PDI with antithrombotic activity in vivo attenuated the release of procoagulant MPs. In addition, P2rx7-/- mice were protected from TF-dependent FeCl3-induced carotid artery thrombosis. BM chimeras revealed that P2X7 receptor prothrombotic function was present in both hematopoietic and vessel wall compartments. In contrast, an alternative anti-PDI antibody showed activities consistent with cellular activation typically induced by P2X7 receptor signaling. This anti-PDI antibody restored TF-dependent thrombosis in P2rx7-/- mice. These data suggest that PDI regulates a critical P2X7 receptor-dependent signaling pathway that generates prothrombotic TF, defining a link between inflammation and thrombosis with potential implications for antithrombotic therapy.

Original languageEnglish (US)
Pages (from-to)2932-2944
Number of pages13
JournalJournal of Clinical Investigation
Volume121
Issue number7
DOIs
StatePublished - Jul 2011

Fingerprint

Purinergic P2X7 Receptors
Thromboplastin
Protein Disulfide-Isomerases
Thrombosis
Myeloid Cells
Antibodies
Carotid Artery Thrombosis
Sulfhydryl Compounds
Oxidoreductases
Adenosine Triphosphate
Macrophages
Inflammation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice. / Furlan-Freguia, Christian; Marchese, Patrizia; Gruber, Andras; Ruggeri, Zaverio M.; Ruf, Wolfram.

In: Journal of Clinical Investigation, Vol. 121, No. 7, 07.2011, p. 2932-2944.

Research output: Contribution to journalArticle

Furlan-Freguia, Christian ; Marchese, Patrizia ; Gruber, Andras ; Ruggeri, Zaverio M. ; Ruf, Wolfram. / P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice. In: Journal of Clinical Investigation. 2011 ; Vol. 121, No. 7. pp. 2932-2944.
@article{90d26c330adb43b6b82de2d9bdbfce43,
title = "P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice",
abstract = "Thrombosis is initiated by tissue factor (TF), a coagulation cofactor/receptor expressed in the vessel wall, on myeloid cells, and on microparticles (MPs) with variable procoagulant activity. However, the molecular pathways that generate prothrombotic TF in vivo are poorly defined. The oxidoreductase protein disulfide isomerase (PDI) is thought to be involved in the activation of TF. Here, we found that in mouse myeloid cells, ATP-triggered signaling through purinergic receptor P2X, ligand-gated ion channel, 7 (P2X7 receptor; encoded by P2rx7) induced activation (decryption) of TF procoagulant activity and promoted release of TF+ MPs from macrophages and SMCs. The generation of prothrombotic MPs required P2X7 receptor-dependent production of ROS leading to increased availability of solvent-accessible extracellular thiols. An antibody to PDI with antithrombotic activity in vivo attenuated the release of procoagulant MPs. In addition, P2rx7-/- mice were protected from TF-dependent FeCl3-induced carotid artery thrombosis. BM chimeras revealed that P2X7 receptor prothrombotic function was present in both hematopoietic and vessel wall compartments. In contrast, an alternative anti-PDI antibody showed activities consistent with cellular activation typically induced by P2X7 receptor signaling. This anti-PDI antibody restored TF-dependent thrombosis in P2rx7-/- mice. These data suggest that PDI regulates a critical P2X7 receptor-dependent signaling pathway that generates prothrombotic TF, defining a link between inflammation and thrombosis with potential implications for antithrombotic therapy.",
author = "Christian Furlan-Freguia and Patrizia Marchese and Andras Gruber and Ruggeri, {Zaverio M.} and Wolfram Ruf",
year = "2011",
month = "7",
doi = "10.1172/JCI46129",
language = "English (US)",
volume = "121",
pages = "2932--2944",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "7",

}

TY - JOUR

T1 - P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice

AU - Furlan-Freguia, Christian

AU - Marchese, Patrizia

AU - Gruber, Andras

AU - Ruggeri, Zaverio M.

AU - Ruf, Wolfram

PY - 2011/7

Y1 - 2011/7

N2 - Thrombosis is initiated by tissue factor (TF), a coagulation cofactor/receptor expressed in the vessel wall, on myeloid cells, and on microparticles (MPs) with variable procoagulant activity. However, the molecular pathways that generate prothrombotic TF in vivo are poorly defined. The oxidoreductase protein disulfide isomerase (PDI) is thought to be involved in the activation of TF. Here, we found that in mouse myeloid cells, ATP-triggered signaling through purinergic receptor P2X, ligand-gated ion channel, 7 (P2X7 receptor; encoded by P2rx7) induced activation (decryption) of TF procoagulant activity and promoted release of TF+ MPs from macrophages and SMCs. The generation of prothrombotic MPs required P2X7 receptor-dependent production of ROS leading to increased availability of solvent-accessible extracellular thiols. An antibody to PDI with antithrombotic activity in vivo attenuated the release of procoagulant MPs. In addition, P2rx7-/- mice were protected from TF-dependent FeCl3-induced carotid artery thrombosis. BM chimeras revealed that P2X7 receptor prothrombotic function was present in both hematopoietic and vessel wall compartments. In contrast, an alternative anti-PDI antibody showed activities consistent with cellular activation typically induced by P2X7 receptor signaling. This anti-PDI antibody restored TF-dependent thrombosis in P2rx7-/- mice. These data suggest that PDI regulates a critical P2X7 receptor-dependent signaling pathway that generates prothrombotic TF, defining a link between inflammation and thrombosis with potential implications for antithrombotic therapy.

AB - Thrombosis is initiated by tissue factor (TF), a coagulation cofactor/receptor expressed in the vessel wall, on myeloid cells, and on microparticles (MPs) with variable procoagulant activity. However, the molecular pathways that generate prothrombotic TF in vivo are poorly defined. The oxidoreductase protein disulfide isomerase (PDI) is thought to be involved in the activation of TF. Here, we found that in mouse myeloid cells, ATP-triggered signaling through purinergic receptor P2X, ligand-gated ion channel, 7 (P2X7 receptor; encoded by P2rx7) induced activation (decryption) of TF procoagulant activity and promoted release of TF+ MPs from macrophages and SMCs. The generation of prothrombotic MPs required P2X7 receptor-dependent production of ROS leading to increased availability of solvent-accessible extracellular thiols. An antibody to PDI with antithrombotic activity in vivo attenuated the release of procoagulant MPs. In addition, P2rx7-/- mice were protected from TF-dependent FeCl3-induced carotid artery thrombosis. BM chimeras revealed that P2X7 receptor prothrombotic function was present in both hematopoietic and vessel wall compartments. In contrast, an alternative anti-PDI antibody showed activities consistent with cellular activation typically induced by P2X7 receptor signaling. This anti-PDI antibody restored TF-dependent thrombosis in P2rx7-/- mice. These data suggest that PDI regulates a critical P2X7 receptor-dependent signaling pathway that generates prothrombotic TF, defining a link between inflammation and thrombosis with potential implications for antithrombotic therapy.

UR - http://www.scopus.com/inward/record.url?scp=79960019927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960019927&partnerID=8YFLogxK

U2 - 10.1172/JCI46129

DO - 10.1172/JCI46129

M3 - Article

C2 - 21670495

AN - SCOPUS:79960019927

VL - 121

SP - 2932

EP - 2944

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 7

ER -